|
|
|
|
|
|
|
|
10.04.25 - 08:54
|
Observe Medical has entered into agreements in principle with major creditors for a 50% debt reduction (Cision)
|
|
Oslo, April 10[th], 2025 – Observe Medical ("the Company" or "Observe Medical") have reached agreements in principle with Convatec and Navamedic to reduce their debt position from in total NOK 82 million to NOK 41 million, with an adjusted payment plan for the remaining debt. Such debt reduction is conditional upon injection of new equity in the minimum amount of NOK 25 million.
The Company has also been in constructive dialogue with existing shareholders and new investors who have indicated willingness to contribute equity in an amount of NOK 25 million, subject to debt reductions being...
|
|
18.03.25 - 20:42
|
Observe Medical ASA: Interim financial report for second half year 2024 (Cision)
|
|
Oslo, March 18, 2025 - Observe Medical ("the Company" or "Observe Medical") today releases its results and interim report for the second half and full year of 2024.
Business update
2024 marked a pivotal transition toward the launch of UnoMeter Safeti Plus, historically the most revenue- and profit-generating product in the Convatec portfolio. Observe Medical is now focused on executing its strategy to reclaim UnoMeter's market position. In 2021, the UnoMeter product portfolio generated approximately NOK 220 million in annual revenue. With an estimated global market potential of NOK...
|
|
|
|
|
|
|
|
|
06.01.25 - 15:06
|
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer (Business Wire)
|
|
LONDON--(BUSINESS WIRE)--#cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Natalia Kozmina is joining the Company as Chief Human Resources Officer (CHRO), effective January 14. Kozmina will lead global human resources, serve on the Executive Leadership Team, and report to Vladimir Makatsaria, Chief Executive Officer.
“Natalia has a deep background in the medtech and life sciences sectors and is a proven enterprise and executive leader in human resources management,” Makatsaria said. “I look forward to collaborating with Natalia to further strengthen our organizational culture and build a thriving environment at LivaNova.”
Kozmina most recently served as Executive Vice President and CHRO of Convatec Group PLC (LSE: CTEC), a London-based global medical technologies company and constituent of the FTSE 100 Index. In this role, she developed and implemented transformative talent strategies to strengthen leadership capabilities across the bus...
|
|
19.11.24 - 12:19
|
Observe Medical ASA: Agreement reached with Convatec to defer payments by 12 months (Cision)
|
|
Oslo, 19 November, 2024 – Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company" or "Observe Medical") on 12 November 2024, in which it inter alia was stated that the Company is in dialogue with strategic and financial partners to evaluate options to further strengthen its working capital situation.
The Company has today, through its subsidiary Observe Medical AS, reached an agreement with Convatec/Unomedical to defer all outstanding payments of consideration pursuant to the asset transfer agreement with Convatec/Unomedical for the...
|
|
|
|